MAIA: Rega Tumbas Perusahaan MAIA Bio

MAIA Bio (MAIA) - logo korporat

MAIA Biotechnology is developing partnerships with oncology centers to accelerate the market launch of targeted drugs. Since the company currently has no commercial products, its stability relies exclusively on investments, and the valuation metric stands at 40.93. The market value dynamics of the asset are presented below. Growth prospects are driven by a strong R&D team that effectively concentrates resources on advancing immunotherapeutic platforms.

MAIA (MAIA Biotechnology) riwayat Nilai Total Perusahaan saka 23.11.2025 nganti 27.10.2026

MAIA Biotechnology - rincian analitis lan metrik utama (MAIA)

- rega lan prakiraan konsensus rega:
Rega saham MAIA Biotech|MAIA - Prakiraan konsensus analis
- data kapitalisasi pasar:
Kapitalisasi pasar MAIA Biotechnology|MAIA - Nilai Perusahaan
- data kapitalisasi buku:
Nilai Buku saben Saham MAIA Biotechnology|MAIA - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku MAIABiotech.com|MAIA - Aset Agregat Perusahaan
- data utang lan likuiditas:
Rasio Utang marang Ekuitas MAIA Biotechnology|MAIA - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas MAIABiotech.com|MAIA - Utang perusahaan|Utang-utang marang nilai buku MAIA Biotechnology
Pambiji fundamental:MAIA Biotech (MAIA)
Produk asli MAIA Biotechnology, Inc.

MAIA Biotechnology is developing breakthrough oncology therapies based on the forced senescence of cancer cells by targeting telomeres. The current enterprise value trend reflects the market valuation of this genetic startup. This metric aggregates market capitalization and debt load, minus available cash. Such a methodology determines the actual cost of a full business buyout. For high-risk biotechs, this serves as a key marker for overpaying for future innovations.

Pesaing MAIA Biotechnology (MAIA)

Nilai Perusahaan ImmunityBio Inc IBRX|Nilai Perusahaan IMCR (Immunocore PLC)|JANX - Rega Tumbas Perusahaan|RCUS: Nilai Perusahaan|ZYME (zymeworks.com) - Nilai Perusahaan|Nilai Total Perusahaan TNGX (Tango Therapeutics, Inc.)|Total Nilai Perusahaan IOVA|Nilai Total Perusahaan Immatics Corp IMTX|Nilai Bisnis Xencor Inc. (XNCR)|Compass Therapeutics - Nilai Perusahaan|replimune.com - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|LYEL (Lyell Immunopharma, Inc.) - Nilai Total Perusahaan|IPHA: Total Nilai Perusahaan|pyxisoncology.com (PYXS) - Nilai Total Perusahaan|CGEN (Compugen) - Nilai Total Perusahaan|Nilai Total Perusahaan IOBT (IO Biotech, Inc.)|Total Nilai Perusahaan sutrobio.com|INKT: Nilai Perusahaan|Nilai Perusahaan Nalika Diakuisisi Penuh werewolftx.com HOWL|IMMX: Rega Nyata Tumbas Perusahaan Kanthi Wutuh|ALXO - Total Nilai Perusahaan|Rega Nyata Tumbas Perusahaan Kanthi Wutuh Cue Biopharma, Inc. (CUE)|PDSB - Nilai Dipunlarasaken Utang lan Kas|sonnetbio.com - Nilai Perusahaan|LIMN (Liminatus Pharma Inc.) - Rega Tumbas Perusahaan|Nilai Total Perusahaan LVTX|Rega Nyata Tumbas Perusahaan Kanthi Wutuh NXTC|Nilai Total Perusahaan LPTX (Leap Therapeutics, Inc.)|Rega Nyata Tumbas Perusahaan Kanthi Wutuh intensitytherapeutics.com INTS|Rega Nyata Tumbas Perusahaan Kanthi Wutuh SNSE (Sensei Biotherapeutics, Inc.)|Theriva Biologics Inc - Nilai Perusahaan|Gritstone Bio (GRTS) - Nilai Total Perusahaan|KA: Nilai Bisnis|Nilai Total Perusahaan NEXI|Total Nilai Perusahaan Turnstone Biologics Corp.|Vaccinex - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Nilai Perusahaan Nalika Diakuisisi Penuh Harpoon Therapeutics Inc (HARP)